Show simple item record

dc.contributor.authorJayaram, A
dc.contributor.authorAttard, G
dc.date.accessioned2016-09-28T12:44:19Z
dc.date.issued2016-06
dc.identifier.citationAnnals of oncology : official journal of the European Society for Medical Oncology, 2016, 27 (6), pp. 962 - 964
dc.identifier.issn0923-7534
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/141
dc.identifier.eissn1569-8041
dc.identifier.doi10.1093/annonc/mdw179
dc.formatPrint-Electronic
dc.format.extent962 - 964
dc.languageeng
dc.language.isoeng
dc.subjectHumans
dc.subjectProstatic Neoplasms
dc.subjectProstate-Specific Antigen
dc.subjectMale
dc.subjectNeoplasm Grading
dc.subjectProstatic Neoplasms, Castration-Resistant
dc.titleDiagnostic Gleason score and castration-resistant prostate cancer.
dc.typeJournal Article
rioxxterms.versionofrecord10.1093/annonc/mdw179
rioxxterms.licenseref.startdate2016-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfAnnals of oncology : official journal of the European Society for Medical Oncology
pubs.issue6
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Treatment Resistance
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Treatment Resistance
pubs.publication-statusPublished
pubs.volume27
pubs.embargo.termsNo embargo
icr.researchteamTreatment Resistanceen_US
dc.contributor.icrauthorAttard, Gerhardten


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record